NEXT Oncology
Highly Engaged Employees
Highly Engaged EmployeesHospitals & Physicians Clinics · Texas, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2829 Babcock Rd Ste 300, San Antonio, Te...Phone Number
(210) 580-9500Website
www.nextoncology.comRevenue
$8.1 MillionIndustry
ZI Rank: 4
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
5
5
4
2
4
About NEXT Oncology
NEXT Oncology, located in San Antonio, Texas, is a Phase 1 center dedicated to providing advanced cancer patients with exceptional care and the latest treatment options. The company focuses on transforming cancer research through the development of breakthrough medicines and offers a community committed to finding a cure. With multiple locations including Austin, Dallas, Houston, and international sites, NEXT Oncology aims to bridge the gap between research and effective cancer treatment through clinical trials. As part of the Avacare business, they provide access to cutting-edge therapies and clinical research opportunities.Explore more
NEXT Oncology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NEXT Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if NEXT Oncology is spiking on competitors!
Funding: Get notified immidiatlly once NEXT Oncology has new funding data
Check if NEXT Oncology has recently received funding, and reach out quickly before it becomes old news!
Click to see if NEXT Oncology had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on NEXT Oncology recently announced quarterly report
NEXT Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when NEXT Oncology launches new products
Congratulate Masked Content for being promoted to Masked Content at NEXT Oncology
Recommended Actions
Find VP level buyers at NEXT Oncology
Find more new buyers
Compare Similar Companies to NEXT Oncology
Compare insights from companies similar to NEXT Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NEXT Oncology is experiencing very low activity levels compared to other companies in the Hospitals & Physicians Clinics sector.
What does this means?
NEXT Oncology is drawing exceptional interest within the Hospitals & Physicians Clinics industry, suggesting notable developments or strong market momentum, learn more about NEXT Oncology.
NEXT Oncology Tech Stack
A closer look at the technologies used by NEXT Oncology
NEXT Oncology News & Media
Worldwide Clinical Trials Expands Site Alliance Collaboration to Support Oncology Trials
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- #CROLeader--Worldwide expands its Site Alliance Collaboration with new partners across the U.S. and Europe to deliver efficient trials with expedited timelines.MatTek Life Sciences and NEXT Oncology Announce Licensing Agreement to Develop Lab-Grown Tumors
The Boston-based biotech company will use an inventory of patient-derived cancer cells to develop new lab-grown tumor models to accelerate and refine oncology research, and provide more targeted treatments for cancer patients. (PRWeb April 18, 2023) Read the full story at https://www.prweb.com/releases/2023/4/prweb19285454.htmDeka Biosciences Announces First-in-Human Dose in Phase 1 Clinical Trial of DK210 (EGFR)
GERMANTOWN, Md., April 5, 2023 /PRNewswire/ -- Deka Biosciences ("Deka"), a clinical-stage biotechnology company focused on developing novel cytokine therapies to treat cancer and inflammatory diseases, announced today that the first subject has been dosed in a Phase 1 clinical trial of...Vial Has Added NEXT Oncology, a Global Network of Phase I Cancer Research Centers, to their Preferred Site Network
SAN FRANCISCO, Nov. 21, 2022 /PRNewswire/ -- Vial has added NEXT Oncology to their Preferred Site Network (PSN). Founded by renowned oncologist Dr. Anthony W. Tolcher, NEXT Oncology is a global network of Phase I cancer research clinics dedicated to providing patients access to the latest...
Read more news
Top Hospitals & Physicians Clinics Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NEXT Oncology
Sign Up For FreeTo access detailed company insights
NEXT Oncology, located in San Antonio, Texas, is a Phase 1 center dedicated to providing advanced cancer patients with exceptional care and the latest treatment options. The company focuses on transforming cancer research through the development of breakthrough medicines and offers a community committed to finding a cure. With multiple locations in... Read More
